New Delhi: Cupid Limited, India’s premier manufacturer and brand of male and female condoms, water-based personal lubricants, IVD kits, deodorants, perfumes, almond hair oil, body oils, petroleum jelly, and other FMCG Products has received a purchase order from Medical Stores Department, Government of Tanzania for supply of male condoms worth ₹42 crore. The order, part of an international framework agreement is to be executed between May to July 2025.
Commenting on this significant milestone, Aditya Halwasiya, Chairman & Managing Director, of Cupid Limited said, “This is great news for us and the Call-Off Order from the Medical Stores Department, Tanzania is a testament to the strong relationships cultivated over the last 15 months by the new team at Cupid.
We have big plans for our B2C and B2B businesses in India and abroad, and our focus remains on growing each business vertical sustainably and profitably. ”
About the Company:
Established in 1993, CUPID Limited is India’s premier manufacturer of male and female condoms, water-based lubricant jelly, and IVD kits. The company boasts a production capacity of up to 480 million male condoms, 52 million female condoms, 210 million sachets of lubricant jelly, and 30 million IVD Test Kits annually. The company has recently launched its CUPID Deodorants, Pocket Perfumes, Toilet Sanitizers, Hair & Body Oils, Hair Removal Sprays, and other FMCG Products.
In March 2024, the company completed a strategic land acquisition in Palava, Maharashtra, enabling it to amplify its production capacity by 1.5 times the existing output. As a result, the annual production capacity will be augmented by approximately 770 million male condoms and 75 million female condoms.
The company has a prominent presence in international markets and is the first company in the world to attain WHO/UNFPA pre-qualification for male and female condoms. CUPID currently exports its products to over 110 countries, with a substantial portion of its revenue generated from international markets. Furthermore, CUPID has established a long-term agreement with WHO/UNFPA. The company is listed on BSE (BSE: 530843) and NSE (NSE: CUPID).
